secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0001104659-24-028788
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals prices $1.5M public offering of 5M shares at $0.30 per share
--------------------------------------------------------------------------------

- Underwritten public offering of 5,000,000 shares of common stock at $0.30/share, gross proceeds approx. $1.5 million.
- EF Hutton LLC sole book-runner; underwriters have 45-day option for up to 750,000 additional shares.
- Proceeds for working capital and general corporate purposes; may repay convertible note to Streeterville Capital.
- Underwriter's warrant issued for up to 250,000 shares at $0.33/share, exercisable after 6 months for 5 years.
- Offering closed Feb 28, 2024; 90-day lock-up for directors, officers, and company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924028788/0001104659-24-028788-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924028788/tm247473d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-028788

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer